Immunai logo

Immunai

New York, NY

Immunai is a biotech company that combines single-cell genomics with ML algorithms to enable high-resolution profiling of the immune system. Immunai's mission is to map the entire immune system and its functions using single-cell genomics and machine learning. Immunai leverages single-cell technologies to profile cells from a blood sample, and uses machine-learning algorithms (powered by its proprietary database) to map the hundreds of cell types and their states to create an immune profile. They work on biomarker discovery and insights that identify how a cell responds to its changing environment. The company is located in New York City, San Francisco, and Tel Aviv, Israel.

immunai.com

Company Details

Founded

2018

Employees

Between 100 - 500 employees

Raised

$295,000,000

Headquarters Location

New York, NY

Public

No

Acquired

No

CEO

Noam SolomonNoam Solomon

Founders

Luis Voloch
Luis Voloch
Danny Wells
Danny Wells
Ansuman Satpathy
Ansuman Satpathy
Dan Littman
Dan Littman
Noam Solomon
Noam Solomon

Company Collections

These are collections Immunai is a part of. Click on the collection name to view similar companies.

Company Collections For Immunai

Immunai's Tech Stack

Immunai's Investors